ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• RTSM/IRT In Clinical Trials: The Complete Guide

  RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.

• Overcoming Cell Therapy Supply Chain Challenges

  For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.

• Avoiding The Risk Of A Non-Transparent Clinical Supply Solution

  With the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.

• Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It

  Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.

• Clinical, Commercial Packaging: Delivering Next-Gen Therapies

  See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

• Considerations When Selecting An Interactive Response Technology Provider

  Interactive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.

• The Dual Sourcing Approach

  Having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.

• The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective

  Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.

• How Long Is Your RTSM Risk Mitigation List?

  While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.

• Trade Wars And Geopolitical Conflict: Navigating US Tariff Changes And The War In Iran

  Tariffs and geopolitical disruptions are reshaping supply chains. Companies must act now to strengthen continuity planning, evaluate tariff recovery opportunities, and build more resilient logistics strategies for the future.